Work

A comparison between cyclin D1- and cyclin D2-expressing myeloma cell lines in terms of DNA damage response, apoptosis induction and proteomic profiling

Year: 2024
Type: dissertation
Abstract: Multiple myeloma is a haematological malignancy with significant molecular heterogeneity. This heterogeneity reflects on the clinical side causing myeloma to be a disease with huge variability in clinical outcomes. Almost all myelomas are initiated from two mutually exclusive molecular events that arise during the premalignant MGUS (Monoclonal Gammopathy of Uncertain Significance) stage. These events involve either an immunoglobulin heavy chain translocation or a triploidy of an odd-numbered chromosome. The first group of events causes the upregulation of either cyclin D1 or cyclin D2. The type of translocation has been shown to have an impact on the prognosis such that the translocations causing a cyclin D2 upregulation have been implicated in an inferior prognosis. It is this group of initiating events that is the focus of this thesis, and our aim was to investigate if there was a differential response between cyclin D1- and cyclin D2- expressing myeloma cell lines following exposure to different stresses. Ionising radiation (IR) was used to induce DNA damage that was compared between the myeloma cell lines. The effect of combining DNA damage with proteasome inhibition was also assessed. To examine the impact of the cyclin D-type on apoptosis induction, the BCL-2 inhibitor venetoclax and the MCL-1 inhibitor S63845 were used as single agents and in combination. The viability and targeted protein expression were analysed prior to full proteomic analysis by mass spectrometry. We have shown the downregulation of cyclin D1 rather than cyclin D2 in response to DNA damage. Most of the DNA damage/DNA damage response happened at the earlier time points after exposure to irradiation and recovered to non-significant levels with ongoing incubation. We have shown that there was no significant impact of the cyclin D-type on the response to proteasome inhibition as a single agent or in combination with IR. There was also no effect when a temporal variation of this combination was tried. The myeloma cell lines used in the project showed more sensitivity to MCL-1 than BCL-2 inhibition. The dual inhibition of both of these antiapoptotic proteins caused a significant synergistic apoptotic response that was generally associated with cyclin D1 and cyclin D2 downregulation. There was no clear differential impact of the cyclin D-type on apoptosis induction however the cyclin D2 cell lines used in this project appeared more sensitive to the dual BCL-2/MCL-1 inhibition. Finally, the proteomic analysis identified the inhibition of several pathways that are associated with protein translation and recycling. Although this project highlighted several interesting results, we were unable to identify a differential response that could be attributed to the underlying cyclin D type.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: green
OpenAlex ID: W7216631104
Cites: 249
Cited by:
Related to: 10